pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-4677 |
Genomic Coordinates | chr1: 243346176 - 243346255 |
Description | Homo sapiens miR-4677 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-4677-5p | |||||||||
Sequence | 13| UUGUUCUUUGGUCUUUCAGCCA |34 | |||||||||
Evidence | Experimental | |||||||||
Experiments | Illumina | DRVs in miRNA |
|
|||||||
SNPs in miRNA |
|
|||||||||
Putative Targets |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | AZIN1 | ||||||||||||||||||||
Synonyms | AZI, AZI1, AZIA1, OAZI, OAZIN, ODC1L | ||||||||||||||||||||
Description | antizyme inhibitor 1 | ||||||||||||||||||||
Transcript | NM_015878 | ||||||||||||||||||||
Other Transcripts | NM_148174 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on AZIN1 | |||||||||||||||||||||
3'UTR of AZIN1 (miRNA target sites are highlighted) |
>AZIN1|NM_015878|3'UTR 1 ACAGGCATTAACGCTTCTTTAGATCTGAAGTTGCAGGTTAAGCTTGTCTGGTCAACATTCCAGTGTGGAAAAATAATTTA 81 AACAATCTTATTCTCTTAATTCTTTTGGCAACAAAAACTATTAGTAATAGCTATTTGGGACCAGACAAAATCAGCTTTCA 161 TCTATAATTCATTGGGGATAATGGGAGATTTAGATAATGTATCCAGATTTAAACCTACCAGTTTGTCCTACCCCTTAAGC 241 GTTTAAAATAAAATATGCAACAAAATGGATGACTTAGTGGAGATGGAAGCCCATTAATTGGGTTCCCCATTAAATCGTTT 321 ACATACAAGAACACAGTTTTTATACTAAGGATTTGTGTTTAAAGTCTTGTAAAGTTCATGTCTTTCACCCAGATATATCA 401 AATGTTAGAAGACCAGTGTGACTTCATTAGATAACGTTTAGTGTATTTAGAATGTGTAAATTTGTGCTTTGAACTGTAGT 481 TTAATAAATGTAAAATTGCATCATAGTATTTGTTGACCTAATGTAACCCTTGTATGATTGCAATAAAATTTTGTGTAGAT 561 TTTACTGTTTTTTCAGGCTAAAACTTTGGGAAAGGGGCTAGCTAGCAAAGGTAGTTTTGAAATAGATGTGTATATGGACT 641 GTTTTGAAGGGTTTTTTTCTTTATAGCCCAGTTAAGTTTTGTTTGGCTCGGTGCATTTTTCATTTATTTAATTAGTAATT 721 TAAGTAAAGTGTTTGGTAAATCATTGTGAAGTTCAGATTCATTATGGAGAGTTGATGTGCAGTAAGCATGATGTTTAACA 801 ATTTTAACACCAAAAATGTTAATCCTGCATAAATCAACTGTAATAATAAATAGGTGTTTCTGTATAGATAGAATGCATAG 881 AGTACCTTAGTAAATCTTTGAATCACAATCTTTTGGCTGAAATGGAAGATTCTGTTAAATACTTTGAATAAACTTGGGGG 961 GAGGGAAATAAAATTGCAGAAAACTGCAGAGCACTAAAACTTAAAGAAGGGCTACATCTTTATCCAGAAACCTGTTGCTC 1041 TTTTGCACGGAATGTTTAAATTCAGAGTTGGGATGGGGGTTGGGGTGAAGCACACTTATTATCTTCAGTTGCAGTGATTT 1121 CAAATTTAGGATTTTTTGTTGTTGGTTTGAACTGTCCCCTTAGTTTCTTGTTATTTCCAATTTGTTCTGCTTAGTCATTA 1201 CTTTTAATTCTTTTCTTACTAAAATTTTATGGTGGTTGGGGGAAGGGAGTTAGCATCACTAACCTGACAGTTGTTGCCAG 1281 GAATTTGCTTTGTTTACTGCTAGTATATTAGAAATCCTAGATCTCAGAATCACAATAGTAATAAACAACAGGGGTCATTT 1361 TTTCCTAACTTACTCTGTGTTCAGGTGTGGAATTTCTGTCTCCCAAGAGGAAATGTGACTTCACTTTGGTGCCAATGGAC 1441 AGAAAATTCTACCTGTGCTACATAGGAGAAGTTTGGAATGCACTTAATAGCTGGTTTTTACACCTTGATTTCGAGGTGGA 1521 AAGAAATTGATCATGAATCTCTAATAAATTTAAATCTCTTAAACCAGTAGGTGCTTAATATTTTTTGATTTGATTAATGC 1601 CCATTTAAATCTCATGGGTTCTATTAAAAATATATATATATAGGGCCCCAATCCATTGCCATCAAATTGCCCTTGGACTT 1681 TTCCAAGGTATATTATGGGGTTTTATGCAAAATTCCAAGCTACCATGTAACTTTTTTTAACCATTTAACAAGGAGGGGGA 1761 ACTGTTTCCTACCTTCTTTACATGTTGTGCATTGTTGTGGTCCAGAAATGCCAAACCTTTTTAAAGATGGTGCAACTTTG 1841 AGTCCTTGGCTTGACTATACAGGCCTTGAACTTCATGGCATATCAACTTTGCCATATCTGCAGGAGAGCTGTTCTATAAG 1921 AAATAGCTCAGAGTTGCAAATATCACATGTGAATGATACGGTAACTTTTAAGAAATGTCTGTATTGTATTTGAAGACTGT 2001 TTGCCATAAATCTGAAATTTGAACCTATGTATTTCAATTTGGTATGCTAAAAAGTTCTGAATTAATGTAAAGTTTTTTGT 2081 TATAATATTGTAATCTCAGTTCAAAAGTTAACTGCAAATATAAAACCCAATGATTTCTATATAGTAAATTGAACTGTAAA 2161 GGTAACTTGTGTGTGATTCTGAATACATAGATAAATGTTTTTATTCCTCATGTTTTACTTTGGCTTCTATCTGAAATAGA 2241 GGTAAAATTTTACATATCAGCTTTA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293 |
Disease | 51582.0 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM714644. RNA binding protein: AGO2. Condition:completeT1
... - Kishore S; Jaskiewicz L; Burger L; Hausser et al., 2011, Nature methods. |
Article |
- Kishore S; Jaskiewicz L; Burger L; Hausser et al. - Nature methods, 2011
Cross-linking and immunoprecipitation (CLIP) is increasingly used to map transcriptome-wide binding sites of RNA-binding proteins. We developed a method for CLIP data analysis, and applied it to compare CLIP with photoactivatable ribonucleoside-enhanced CLIP (PAR-CLIP) and to uncover how differences in cross-linking and ribonuclease digestion affect the identified sites. We found only small differences in accuracies of these methods in identifying binding sites of HuR, which binds low-complexity sequences, and Argonaute 2, which has a complex binding specificity. We found that cross-link-induced mutations led to single-nucleotide resolution for both PAR-CLIP and CLIP. Our results confirm the expectation from original CLIP publications that RNA-binding proteins do not protect their binding sites sufficiently under the denaturing conditions used during the CLIP procedure, and we show that extensive digestion with sequence-specific RNases strongly biases the recovered binding sites. This bias can be substantially reduced by milder nuclease digestion conditions.
LinkOut: [PMID: 21572407]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | C8166 , TZM-bl |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM1462572. RNA binding protein: AGO2. Condition:C8166 NL4-3
PAR-CLIP data was present in GSM1462574. RNA binding protein: AGO2. Condition:TZM-bl ami BaL
... - Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio. |
Article |
- Whisnant AW; Bogerd HP; Flores O; Ho P; et al. - mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
|
CLIP-seq Support 1 for dataset GSM4903833 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_a |
Location of target site | NM_148174 | 3UTR | AGCGUUUAAAAUAAAAUAUGCAACAAAAUGGAUGACUUAGUGGAGAUGGAAGCCCAUUAAUUGGGUUCCCCAUUAAAUCGUUUACAUACAAGAACACAGUUUUUAUACUAAGGAUUUGUGUUUAAAGUCUUGUAAAGUUC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM714644 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / completeT1, repA |
Location of target site | ENST00000337198.5 | 3UTR | UUCCCCAUUAAAUCGUUUACAUACAAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 21572407 / GSE28865 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset GSM1462572 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | C8166 / C8166 NL4-3 |
Location of target site | ENST00000337198.5 | 3UTR | UUCCCCAUUAAAUCGUUUACAUACAAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
CLIP-seq Support 4 for dataset GSM1462574 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | TZM-bl / TZM-bl ami BaL |
Location of target site | ENST00000337198.5 | 3UTR | UUCCCCAUUAAAUCGUUUACAUACAAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
84 hsa-miR-4677-5p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT080553 | PMAIP1 | phorbol-12-myristate-13-acetate-induced protein 1 | 2 | 2 | ||||||||
MIRT089446 | STAMBP | STAM binding protein | 2 | 2 | ||||||||
MIRT135057 | ADSS | adenylosuccinate synthase | 2 | 4 | ||||||||
MIRT263519 | RPS24 | ribosomal protein S24 | 2 | 2 | ||||||||
MIRT357966 | GRPEL2 | GrpE like 2, mitochondrial | 2 | 2 | ||||||||
MIRT384298 | GOLT1B | golgi transport 1B | 2 | 2 | ||||||||
MIRT407003 | CEBPB | CCAAT/enhancer binding protein beta | 2 | 2 | ||||||||
MIRT442312 | UBE2Q1 | ubiquitin conjugating enzyme E2 Q1 | 2 | 2 | ||||||||
MIRT443782 | ST13 | ST13, Hsp70 interacting protein | 2 | 2 | ||||||||
MIRT446864 | NBPF3 | NBPF member 3 | 2 | 2 | ||||||||
MIRT447642 | RAB3GAP1 | RAB3 GTPase activating protein catalytic subunit 1 | 2 | 2 | ||||||||
MIRT448464 | SLC45A4 | solute carrier family 45 member 4 | 2 | 2 | ||||||||
MIRT449117 | XRRA1 | X-ray radiation resistance associated 1 | 2 | 2 | ||||||||
MIRT450240 | TRIM66 | tripartite motif containing 66 | 2 | 2 | ||||||||
MIRT450265 | F2RL2 | coagulation factor II thrombin receptor like 2 | 2 | 2 | ||||||||
MIRT450682 | RPN2 | ribophorin II | 2 | 2 | ||||||||
MIRT465594 | TNRC6A | trinucleotide repeat containing 6A | 2 | 2 | ||||||||
MIRT481118 | AZIN1 | antizyme inhibitor 1 | 2 | 4 | ||||||||
MIRT497203 | CDH7 | cadherin 7 | 2 | 4 | ||||||||
MIRT502954 | CCNT2 | cyclin T2 | 2 | 2 | ||||||||
MIRT506337 | NUP54 | nucleoporin 54 | 2 | 4 | ||||||||
MIRT509224 | KIF14 | kinesin family member 14 | 2 | 6 | ||||||||
MIRT514595 | NDUFA12 | NADH:ubiquinone oxidoreductase subunit A12 | 2 | 4 | ||||||||
MIRT515392 | ARHGAP21 | Rho GTPase activating protein 21 | 2 | 4 | ||||||||
MIRT525555 | MTRNR2L7 | MT-RNR2-like 7 | 2 | 6 | ||||||||
MIRT525604 | MTRNR2L3 | MT-RNR2-like 3 | 2 | 4 | ||||||||
MIRT533249 | VCAM1 | vascular cell adhesion molecule 1 | 2 | 2 | ||||||||
MIRT535778 | MTRNR2L11 | MT-RNR2-like 11 | 2 | 6 | ||||||||
MIRT535799 | MTRNR2L10 | MT-RNR2-like 10 | 2 | 4 | ||||||||
MIRT552784 | YAF2 | YY1 associated factor 2 | 2 | 2 | ||||||||
MIRT556213 | MB21D2 | Mab-21 domain containing 2 | 2 | 2 | ||||||||
MIRT558192 | EIF2S1 | eukaryotic translation initiation factor 2 subunit alpha | 2 | 4 | ||||||||
MIRT565809 | SDCCAG3 | serologically defined colon cancer antigen 3 | 2 | 2 | ||||||||
MIRT566341 | POLDIP2 | DNA polymerase delta interacting protein 2 | 2 | 2 | ||||||||
MIRT567792 | DEK | DEK proto-oncogene | 2 | 2 | ||||||||
MIRT572455 | ZNF516 | zinc finger protein 516 | 2 | 2 | ||||||||
MIRT572582 | HGFAC | HGF activator | 2 | 2 | ||||||||
MIRT573357 | PDE3A | phosphodiesterase 3A | 2 | 2 | ||||||||
MIRT574649 | LMAN2 | lectin, mannose binding 2 | 2 | 2 | ||||||||
MIRT608164 | ERBB2 | erb-b2 receptor tyrosine kinase 2 | 2 | 2 | ||||||||
MIRT610690 | FAM89A | family with sequence similarity 89 member A | 2 | 2 | ||||||||
MIRT618457 | TMCO1 | transmembrane and coiled-coil domains 1 | 2 | 2 | ||||||||
MIRT621924 | SYAP1 | synapse associated protein 1 | 2 | 4 | ||||||||
MIRT622279 | SH3TC2 | SH3 domain and tetratricopeptide repeats 2 | 2 | 2 | ||||||||
MIRT624610 | B3GALT5 | beta-1,3-galactosyltransferase 5 | 2 | 2 | ||||||||
MIRT631040 | TAS2R30 | taste 2 receptor member 30 | 2 | 2 | ||||||||
MIRT636153 | TRPS1 | transcriptional repressor GATA binding 1 | 2 | 2 | ||||||||
MIRT638255 | SIX1 | SIX homeobox 1 | 2 | 2 | ||||||||
MIRT638330 | RCAN1 | regulator of calcineurin 1 | 2 | 2 | ||||||||
MIRT641621 | KIAA1244 | ARFGEF family member 3 | 3 | 3 | ||||||||
MIRT644556 | SPOP | speckle type BTB/POZ protein | 2 | 2 | ||||||||
MIRT645900 | LRIF1 | ligand dependent nuclear receptor interacting factor 1 | 2 | 2 | ||||||||
MIRT649115 | SRD5A1 | steroid 5 alpha-reductase 1 | 2 | 2 | ||||||||
MIRT652244 | TPI1 | triosephosphate isomerase 1 | 2 | 2 | ||||||||
MIRT657249 | ICOSLG | inducible T-cell costimulator ligand | 2 | 2 | ||||||||
MIRT659857 | CAPRIN1 | cell cycle associated protein 1 | 2 | 4 | ||||||||
MIRT665369 | XIAP | X-linked inhibitor of apoptosis | 2 | 2 | ||||||||
MIRT669214 | CAND1 | cullin associated and neddylation dissociated 1 | 2 | 2 | ||||||||
MIRT682579 | CPA4 | carboxypeptidase A4 | 2 | 2 | ||||||||
MIRT698725 | STX6 | syntaxin 6 | 2 | 4 | ||||||||
MIRT699788 | SEC24A | SEC24 homolog A, COPII coat complex component | 2 | 2 | ||||||||
MIRT700290 | RABGEF1 | RAB guanine nucleotide exchange factor 1 | 2 | 2 | ||||||||
MIRT710374 | LMBR1 | limb development membrane protein 1 | 2 | 2 | ||||||||
MIRT710407 | YTHDC1 | YTH domain containing 1 | 2 | 2 | ||||||||
MIRT710569 | TNPO1 | transportin 1 | 2 | 2 | ||||||||
MIRT711384 | PLEKHG4B | pleckstrin homology and RhoGEF domain containing G4B | 2 | 2 | ||||||||
MIRT712042 | STYK1 | serine/threonine/tyrosine kinase 1 | 2 | 2 | ||||||||
MIRT712717 | NCAPG2 | non-SMC condensin II complex subunit G2 | 2 | 2 | ||||||||
MIRT713288 | ADAMTS20 | ADAM metallopeptidase with thrombospondin type 1 motif 20 | 2 | 2 | ||||||||
MIRT715649 | USP6NL | USP6 N-terminal like | 2 | 2 | ||||||||
MIRT716167 | FAM71F2 | family with sequence similarity 71 member F2 | 2 | 2 | ||||||||
MIRT716756 | TRABD2A | TraB domain containing 2A | 2 | 2 | ||||||||
MIRT718209 | TNRC6C | trinucleotide repeat containing 6C | 2 | 2 | ||||||||
MIRT718361 | SOX1 | SRY-box 1 | 2 | 2 | ||||||||
MIRT718806 | SLC25A33 | solute carrier family 25 member 33 | 2 | 2 | ||||||||
MIRT719339 | VGLL4 | vestigial like family member 4 | 2 | 2 | ||||||||
MIRT719671 | SPDYE1 | speedy/RINGO cell cycle regulator family member E1 | 2 | 2 | ||||||||
MIRT720827 | C1orf52 | chromosome 1 open reading frame 52 | 2 | 2 | ||||||||
MIRT722184 | DNAJC9 | DnaJ heat shock protein family (Hsp40) member C9 | 2 | 2 | ||||||||
MIRT722398 | BCAS2 | BCAS2, pre-mRNA processing factor | 2 | 2 | ||||||||
MIRT723460 | ST8SIA3 | ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 3 | 2 | 2 | ||||||||
MIRT724072 | NCKAP1L | NCK associated protein 1 like | 2 | 2 | ||||||||
MIRT724594 | AP3B1 | adaptor related protein complex 3 beta 1 subunit | 2 | 2 | ||||||||
MIRT725234 | PDE1B | phosphodiesterase 1B | 2 | 2 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|